GS
GSK
GSK·NYSELondon UKFounded 200072,000 employees
Large CappharmaPublicInfectious DiseaseOncologyImmunologyRespiratory
Platform: Vaccines & Bio
Market Cap
$80B
All Drugs
12
Clinical Trials
21
Failed / Terminated
4
FDA Approved
0
Stock Price & Catalysts (GSK)
Loading GSK stock data...
Drug Pipeline (12 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GSK-6983 | GSK-6983 | Phase 2 | 1 | ALK | SchizophreniaPTSD | ||
| Motarapivir | GSK-6551 | Preclinical | 2 | AuroraA | ALLHeart Failure | ||
| Zanumavacamten | GSK-5385 | Phase 2/3 | 1 | TROP-2 | MDSADHD | ||
| Fixatenlimab | GSK-8381 | Phase 1/2 | 2 | JAK1 | DMDSLE | ||
| Zenonesiran | GSK-4504 | Preclinical | 1 | DLL3 | DMDHemophilia A | ||
| GSK-6516 | GSK-6516 | Phase 1/2 | 1 | MALT1 | MesoCervical Ca | ||
| GSK-4334 | GSK-4334 | Preclinical | 2 | CD47 | LN | ||
| Suracagene | GSK-121 | Phase 3 | 2 | PRMT5 | CholangiocarcinomaPompe | ||
| GSK-2051 | GSK-2051 | Phase 1 | 2 | PSMA | Heart FailureDLBCL | ||
| Ivotuximab | GSK-7613 | NDA/BLA | 2 | GIP-R | Bladder CaPancreatic Ca | ||
| GSK-7987 | GSK-7987 | Phase 3 | 4 | MDM2 | MG | ||
| Olpatinib | GSK-4731 | Preclinical | 1 | PD-L1 | MSAS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (21)